CYTX - Cytori Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue6,41111,38011,659
Cost of Revenue1,3182,1703,186
Gross Profit5,0939,2108,473
Operating Expenses
Research Development11,67816,19719,000
Selling General and Administrative11,18712,1744,759
Non Recurring1,6861,6861,686
Others1,225545545
Total Operating Expenses25,776--
Operating Income or Loss-20,683-19,706-15,286
Income from Continuing Operations
Total Other Income/Expenses Net46252-79
Earnings Before Interest and Taxes-20,637-19,454-15,365
Interest Expense2,0492,5923,379
Income Before Tax-22,686-22,046-18,744
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-22,686-22,046-19,004
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-22,686-22,046-18,744
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-26,663-22,046-19,405